← Eichor
Study identifier: NCT07324070 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

Condition: Major Depressive Disorder (MDD) · Treatment Resistant Depression (TRD)  ·  Sponsor: Charles University, Czech Republic

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Divacky  ·  +420 224 965 357  ·  daniel.divacky@lf1.cuni.cz

Always discuss trial participation with your own doctor first.

Locations (1)

General University Hospital, Psychiatry departmentPrague, Czech, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07324070